Latest advances in artificial intelligence (AI) in multiple sclerosis (MS) segmentation. "Deep Learning-Based Automated MS T2 Lesion Segmentation." Bioclinica's Director of Neuroscience, Luc Bracoud, will present our latest image analysis developments applied to MS during the October 12th poster session at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Congress in Berlin. View the ECTRIMS program for session details: P1138 - Deep-learning based automated MS T2 lesion segmentation, presented by Luc Bracoud, Director of Neuroscience, Bioclinica.
To learn about the application of AI in MS and other recent developments and how Bioclinica's domain experts can support your MS trials, submit a Contact Us form and we will direct your request to Luc Bracoud and Dr. Joyce Suhy.